Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy
Abstract
Share and Cite
Salveridou, K.; Tzamalis, T.; Klaiber-Hakimi, M.; Haase, S.; Gröpper, S.; Giagounidis, A. Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy. Hematol. Rep. 2024, 16, 585-592. https://doi.org/10.3390/hematolrep16040057
Salveridou K, Tzamalis T, Klaiber-Hakimi M, Haase S, Gröpper S, Giagounidis A. Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy. Hematology Reports. 2024; 16(4):585-592. https://doi.org/10.3390/hematolrep16040057
Chicago/Turabian StyleSalveridou, Konstantina, Theodoros Tzamalis, Maika Klaiber-Hakimi, Sabine Haase, Stefanie Gröpper, and Aristoteles Giagounidis. 2024. "Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy" Hematology Reports 16, no. 4: 585-592. https://doi.org/10.3390/hematolrep16040057